Evotec AG
Schnackenburgalle 114
Hamburg
22525
Germany
Tel: 49-40-560810
Fax: 49-40-56081222
Website: http://www.evotec.de/
Email: info@evotecoai.com
573 articles about Evotec AG
-
Evotec AG Announces the Acquisition of all Shares of Neuro3d
3/29/2007
-
Evotec AG Announces Encouraging FY 2006 Financial Results
3/29/2007
-
Evotec OAI (Germany) Initiates its First Phase I Clinical Study With EVT 302
3/22/2007
-
Evotec OAI (Germany) and Boehringer Ingelheim Corporation Enter Into Target Discovery Collaboration in Alzheimer's Disease
3/19/2007
-
Evotec OAI (Germany) and Interprotein Sign Collaboration Agreement to Develop Interleukin 6 Inhibitors
2/28/2007
-
Evotec OAI (Germany) R&D Update On 19 February Live On The Internet
2/16/2007
-
Evotec OAI (Germany) To Present At The Biotechnology Industry Organization (BIO) CEO & Investor Conference 2007 In New York And To Participate In The Panel Addressing Novel Approaches To The Treatment Of Insomnia
2/9/2007
-
Evotec OAI (Germany) Initiates Second Phase II Clinical Trial With Insomnia Drug EVT 201
11/17/2006
-
Evotec Initiates Second Phase II Clinical Trial With Insomnia Drug EVT 201
11/17/2006
-
Evotec OAI (Germany) Reports Strong Q3 Growth
11/9/2006
-
Evotec OAI (Germany) Achieves Certificate Of GMP Compliance From MHRA
9/28/2006
-
Evotec OAI (Germany) To Present At The UBS Warburg Global Life Sciences Conference
9/22/2006
-
Evotec OAI (Germany) Initiates Phase II Clinical Trial With EVT 201 For The Treatment Of Insomnia
9/21/2006
-
Evotec OAI (Germany) Appoints David Brister Chief Business Officer
9/19/2006
-
Evotec OAI (Germany) Discontinues Phase 1 EVT 301 Development Program
9/14/2006
-
Evotec OAI (Germany) Reaches Second Milestone And Receives Success Payment In Alzheimer's Disease Collaboration With Takeda Pharmaceutical Co. Ltd.
8/16/2006
-
Evotec OAI (Germany) Reports Encouraging Results For The First Half Year And Confirms Guidance
8/11/2006
-
CHDI, Inc. Selects Evotec As Strategic Drug Discovery Partner In The Search For Huntington Disease Treatments
8/10/2006
-
Evotec OAI (Germany) Successfully Completes Phase I For Potential Alzheimer's Disease And Neuropathic Pain Treatment, EVT 101
8/8/2006
-
Olympus Corporation Acquires Single Module Fluorescence Spectroscopy Technology And IP Portfolio From Evotec OAI (Germany)
7/26/2006